Clinical Trial

Apical Suspension Repair for Vault Prolapse In a Three-Arm Randomized Trial Design

Study acronym: ASPIRe
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study is a multi-center, randomized, surgical trial of women with symptomatic post-hysterectomy apical (cuff) prolapse desiring surgical treatment. This study will compare the three available surgical treatments performed in usual practice. The purpose of this study is to compare two commonly performed mesh apical repair (sacral colpopexy vs. Apical Transvaginal Mesh) and vaginal native tissue apical repairs with mesh reinforced repairs. The primary outcome is measured over time (up to 60 months) using a survival analysis approach. Participants will be followed for at least 36-months (3-years) post surgery and up to a maximum of 60-months (5-years) during the primary trial. Participants who complete the primary trial will be approached for consent for long-term follow-up as part of a study extension and will be followed up to a maximum of 120-months (10-years). The investigators hypothesize that treatment failure will not differ between vaginally and abdominally placed mesh for vault vaginal prolapse, and mesh repairs (regardless of route of implantation) will be superior to native tissue apical suspension.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2016-02-08; most recent amendment 2025-08-06.
Status change: Recruiting → Active, Not Recruiting 2019-04-29
Status change: Not Yet Recruiting → Recruiting 2016-03-24
Trial Details
NCT Number NCT02676973
Lead Sponsor NICHD Pelvic Floor Disorders Network
Collaborators: The Cleveland Clinic, University of Alabama at Birmingham, University of California, San Diego, Duke University, University of New Mexico, Women and Infants Hospital of Rhode Island, RTI International, University of Pennsylvania, University of Pittsburgh, Kaiser Permanente, University of Texas Southwestern Medical Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Visceral Prolapse
Enrollment 360 participants
Start Date 2016-02-29
Primary Completion 2022-07-28 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-26